- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06879639
Exercise Impact in Elderly With Multimorbidity: HbA1c and Blood Pressure
The Effect of 10 Weeks of Physical Exercise on Glycated Hemoglobin and Blood Pressure in Elderly People With Multimorbidity Conditions: a Controlled and Randomized Study
The main objective of the study is to compare the effect of two different types of physical exercise modalities on glycated hemoglobin and blood pressure in elderly individuals with multimorbidity. The main characteristic of the proposal is that it is experimental, with two intervention groups with physical exercise that will be randomized in the order of participation of the groups and forwarded to the researchers regarding the evaluations and training periods. In addition, the study will be controlled, as it has a control group that will not perform any intervention with physical exercises during the study period. To allocate the participants in each exercise group and for the control group, the researchers will use the 1:1 method, the user will receive an automatic generator through the random.org website.
The main questions raised by the studies will be: Is land-based training more effective than aquatic training for this population in improving the primary outcomes? Is there a difference between training at these intensities and not doing any physical exercise in this population with these primary outcomes?
Participants in the 2 intervention groups will:
Train 3x per week for 10 weeks at intensities that will progress over the weeks.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Braga District
-
Vila Nova de Famalicão, Braga District, Portugal, 4760-104
- Municipal Pavilion of Vila Nova de Famalicão
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Being elderly adult 60 years old
- Having grade 1 medicated hypertension (systolic blood pressure ≥ 140 and diastolic blood pressure ≥ 90) or having type 2 diabetes mellitus
- Volunteers may have other morbidities such as: anxiety/depression, knee osteoarthritis or obesity
- Be fit for the practice of physical activity
Exclusion Criteria:
- Being a smoker
- Have severe musculoskeletal problems that prevent you from carrying out physical activities
- Unable to carry out the protocol completely
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Combined physical exercise in land
Combined physical exercise performed in gym 3 times per week
|
The workout routine for the Land Exercise (LE) group will be segmented as follows: A cardio segment (15-20 minutes) involving treadmill walking/running or cycling on the stationary bike; A strength training segment (35 minutes) comprising bench press, seated row, leg extension, squats, pull down, peck-deck, hamstring curls, curl-ups, and back extensions; and a cool-down phase (5-10 minutes) featuring stretching exercises.
Other Names:
The activities for the Water Exercise (WE) group will be divided into segments: An aerobic portion (15-20 minutes) involving water walking and jogging combined with arm movements; A resistance portion (35 minutes) including chest/upper back guidance, chest back press, behind-the-back press, pivoted shoulder press (upper body), and calf lifts, supported squats, outer/inner thigh scissors, and forward and back leg glide (lower body), and finally, a cool-down period (5-10 minutes) comprising stretching exercises.
Other Names:
|
|
Experimental: Combined physical exercise in water
Combined physical exercise performed in water 3 times per week.
|
The workout routine for the Land Exercise (LE) group will be segmented as follows: A cardio segment (15-20 minutes) involving treadmill walking/running or cycling on the stationary bike; A strength training segment (35 minutes) comprising bench press, seated row, leg extension, squats, pull down, peck-deck, hamstring curls, curl-ups, and back extensions; and a cool-down phase (5-10 minutes) featuring stretching exercises.
Other Names:
The activities for the Water Exercise (WE) group will be divided into segments: An aerobic portion (15-20 minutes) involving water walking and jogging combined with arm movements; A resistance portion (35 minutes) including chest/upper back guidance, chest back press, behind-the-back press, pivoted shoulder press (upper body), and calf lifts, supported squats, outer/inner thigh scissors, and forward and back leg glide (lower body), and finally, a cool-down period (5-10 minutes) comprising stretching exercises.
Other Names:
|
|
Experimental: Control Group
The control group will not performed physical exercise for ten weeks.
|
The control group will not receive any formal indication or support to perform structured exercise training but will be allowed to engage in physical activity ad libitum.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Glycated hemoglobin (Hb1Ac)
Time Frame: 10 weeks
|
In the pre- and post-training moments during the morning and fasting period, venous blood samples will be collected to analyze the glycemic profile.
The outcome measure will be expressed as a percentage (%), representing the average blood glucose level over the last 2 to 3 months.
|
10 weeks
|
|
Blood pressure
Time Frame: 10 weeks
|
Office blood pressure (OBP) will be evaluated and monitored during pre-training moments using automatic monitors, and Home Blood Pressure Monitoring (HBPM) will be conducted with appropriate collection devices according to the 2021 European Society of Hypertension practice guidelines for office and out-of-office blood pressure measurement.The results of Systolic Blood Pressure (SBP) and Diastolic Blood Pressure (DBP) will be shown in millimeters of mercury (mmHg) for OBP and HBPM.
|
10 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Heart rate variability
Time Frame: 10 weeks
|
Heart rate will be monitored through a heart rate monitor (POLAR® HR monitor model RS800cx (recording frequency: 1000Hz), consequently obtaining heart rate variability, and such collection will take place in a sitting position with spontaneous breathing, for 20 minutes at total rest at the appropriated local
|
10 weeks
|
|
Lipid Profile (LDL, HDL, VLDL and Triglycerides)
Time Frame: 10 weeks
|
In the pre- and post-training moments during the morning and fasting period, venous blood samples will be collected to analyze the lipid (LDL; HDL; VLDL; triglycerides and total cholesterol).
The unit of measurement used to express the results will be mg/dL.
|
10 weeks
|
|
Body Mass Index (BMI)
Time Frame: 10 weeks
|
The participants' body mass and height will be measured using bioimpedance and a stadiometer, respectively.
Thus, researchers will have access to the BMI weight (kg)/height (m2).
|
10 weeks
|
|
Fasting glucose
Time Frame: 10 weeks
|
In the pre- and post-training moments during the morning and fasting period, venous blood samples will be collected to analyze the glycemic profile by fasting glucose (mg/dL).
|
10 weeks
|
|
Agility
Time Frame: 10 weeks
|
Agility and mobility will be assessed with the Timed up and go test.
All testing protocol will be followed and results will be displayed as per guidelines.
|
10 weeks
|
|
Cardiorespiratory fitness
Time Frame: 10 weeks
|
The 6-minute walk test will be performed to measure the cardiorespiratory capacity of the elderly.
It will be carried out according to the proposed guidelines
|
10 weeks
|
|
Hand grip strength
Time Frame: 10 weeks
|
The handgrip strength test will be performed with a calibrated device and the test protocol will be guided by official guidelines.
|
10 weeks
|
|
Sit and stand test
Time Frame: 10 weeks
|
The test will measure the strength of the lower limbs of elderly people and will be guided by official guidelines
|
10 weeks
|
|
Balance test
Time Frame: 10 weeks
|
Balance will be analyzed through a biomechanical assessment with a force platform for each volunteer.
|
10 weeks
|
|
Muscle electrical activity
Time Frame: 10 weeks
|
The electrical activity of the vastus medialis and lateralis muscles will be assessed with surface electromyography electrodes.
|
10 weeks
|
|
World Health Organization Quality of Life - WHOQOL questionnaire
Time Frame: 10 weeks
|
Quality of life will be measured using the World Health Organization Quality of Life - WHOQOL questionnaire validated for the Portuguese language.The WHOQOL uses a scoring system ranging from 1 to 5, with responses varying according to the intensity, frequency, or severity of each item.
The instrument is structured into four primary domains and includes several supplementary items.
In the summation, the score ranges from a minimum of 4, indicating poor quality of life, to a maximum of 20, reflecting a good quality of life.
|
10 weeks
|
|
Internation Physical Activity - IPAQ questionnaire
Time Frame: 10 weeks
|
The Internation Physical Activity - IPAQ questionnaire will measure each participant's level of physical activity.
It includes items regarding the frequency, duration, and intensity of physical activity undertaken in the previous week.
The summation of responses results in a total score that is categorized into low, moderate, or high levels of physical activity.
Higher scores indicate greater physical activity, which correlates with enhanced physical fitness and overall health.
|
10 weeks
|
|
Pittsburgh Sleep Quality Index - PSQIquestionnaire
Time Frame: 10 weeks
|
Sleep quality level will be measured using the Pittsburgh Sleep Quality Index -PSQI questionnaire.
The questionnaire consists of 19 items that cover various dimensions of sleep, including sleep latency, duration, disturbances, efficiency, and medication use.
These items are grouped into seven component scores, which are aggregated to derive a global score.
The total PSQI score ranges from 0 to 21, with higher scores indicating poorer sleep quality.
A global score greater than 5 typically indicates significant sleep disturbances, while lower scores reflect better sleep quality.
|
10 weeks
|
|
Depression, Anxiety, and Stress Scale - DASS 21
Time Frame: 10 weeks
|
Depression, anxiety and stress will be measured using a scale given by the Depression, Anxiety, and Stress Scale - DASS 21 questionnaire.
The scale is composed of 21 items, divided into three subscales: depression, anxiety, and stress, each consisting of 7 items.
Participants rate each item on a 4-point Likert scale, ranging from 0 (not at all) to 3 (very much or most of the time), reflecting the frequency of symptoms experienced during the previous week.
Subscale scores are computed by summing the item responses within each subscale.
Higher scores indicate greater severity of depression, anxiety, or stress.
The resulting scores are classified into severity levels, ranging from normal to extremely severe.
|
10 weeks
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Daniel M Gonçalves, Professor, Universidade do Porto
- Principal Investigator: Victor Hugo V Carrijo, MsC. Physioterapy, Universidade do Porto
- Principal Investigator: Mario Jorge O Costa, Professor, Universidade do Porto
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Endocrine System Diseases
- Musculoskeletal Diseases
- Vascular Diseases
- Cardiovascular Diseases
- Arthritis
- Joint Diseases
- Rheumatic Diseases
- Metabolic Diseases
- Respiratory Tract Diseases
- Glucose Metabolism Disorders
- Lipid Metabolism Disorders
- Nutritional and Metabolic Diseases
- Hypertension
- Osteoarthritis
- Diabetes Mellitus
- Dyslipidemias
- Respiration Disorders
- Motor Activity
- Movement
- Musculoskeletal Physiological Phenomena
- Musculoskeletal and Neural Physiological Phenomena
- Investigative Techniques
- Epidemiologic Research Design
- Epidemiologic Methods
- Research Design
- Methods
- Inorganic Chemicals
- Anions
- Ions
- Electrolytes
- Hydroxides
- Alkalies
- Oxides
- Oxygen Compounds
- Exercise
- Control Groups
- Water
Other Study ID Numbers
- CEFADE 27_2024
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertension
-
University of Alabama at BirminghamTroy UniversityCompletedHypertension | Hypertension, Resistant to Conventional Therapy | Uncontrolled Hypertension | Hypertension, White CoatUnited States
-
National Taiwan University Hospital Hsin-Chu BranchRecruitingHypertension,Essential | Hypertension, MaskedTaiwan
-
Franz Rischard, DOAcceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway...Not yet recruitingPulmonary Hypertension | Pulmonary Arterial Hypertension (PAH)United States
-
Abant Izzet Baysal UniversityNot yet recruitingPRIMARY HYPERTENSIONTurkey (Türkiye)
-
SingHealth PolyclinicsNanyang PolytechnicEnrolling by invitationHypertension,EssentialSingapore
-
Hacettepe UniversityBozok UniversityCompletedHypertension | Arterial Hypertension | Systemic HypertensionTurkey (Türkiye)
-
BackBeat Medical IncNot yet recruitingHypertension, Systolic | Hypertension (HTN) | Heart Failure With Preserved Ejection Fraction (HFpEFGeorgia
-
Xuanwu Hospital, BeijingNot yet recruiting
-
Shenzhen Salubris Pharmaceuticals Co., Ltd.Not yet recruiting
-
Instituto de Cardiologia do Rio Grande do SulCompletedHypertension (HTN) | Hypertension ArterialBrazil
Clinical Trials on Exercise
-
National Institute of Neurological Disorders and...TerminatedTraumatic Brain InjuryUnited States
-
University of Texas, El PasoRecruitingKnee Osteoarthritis | Knee Pain Chronic | Central Pain SyndromeUnited States
-
Aksaray University Training and Research HospitalCompletedExercise Training | Lactate Blood Increase | Cognitive Functions | BDNFTurkey (Türkiye)
-
Bayero University Kano, NigeriaCompletedChronic Low Back PainNigeria
-
Toronto Rehabilitation InstituteCompletedAcute Myeloid LeukemiaCanada
-
University of Alabama at BirminghamCompletedCystic FibrosisUnited States
-
Center for Health, Exercise and Sport Sciences,...CompletedSedentary LifestyleSerbia
-
Heitor Moreno JuniorUnknown
-
Middle East Technical UniversityCompletedOsteoarthritis | Degenerative Lesion of Articular Cartilage of Knee | Articular Cartilage Disorder of KneeTurkey
-
University College CorkRecruitingDepressive Disorder, MajorIreland